Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
64 hedge funds and large institutions have $32.6M invested in Applied Genetic Technologies Corporation in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 4 closing their positions.
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
19% more funds holding
Funds holding: 54 → 64 (+10)
4% more capital invested
Capital invested by funds: $31.4M → $32.6M (+$1.22M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.22M |
| 2 |
Renaissance Technologies
New York
|
+$651K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$460K |
| 4 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$332K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$323K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$676K |
| 2 |
Man Group
London,
United Kingdom
|
-$402K |
| 3 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
-$331K |
| 4 |
BlackRock
New York
|
-$237K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$198K |
AGTC Hedge Fund Activity: Q2 2018 in Review
64 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2018, worth a combined $32.6M — up 3.9% from $31.4M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AGTC positions and 4 closed out — a net gain of 10 holders — while 18 added to existing stakes and 18 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.22M. The largest seller was Fidelity Investments, cutting an estimated $676K.
- 64 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2018, up from 54 in Q1 2018.
- Funds reported $32.6M of Applied Genetic Technologies Corporation stock for Q2 2018, up 3.9% quarter-over-quarter.
- 14 funds opened new Applied Genetic Technologies Corporation positions in Q2 2018 and 4 closed out, a net change of +10 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2018 was T. Rowe Price Associates, an estimated $1.22M added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2018 was Fidelity Investments, an estimated $676K sold.
Based on aggregated 13F filings for Q2 2018.